cAMP Response Element-Binding Protein Deficiency Allows for Increased Neurogenesis and a Rapid Onset of Antidepressant Response
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
cAMP response element-binding protein (CREB) has been implicated in the molecular and cellular mechanisms of chronic antidepressant (AD) treatment, although its role in the behavioral response is unclear. CREB-deficient (CREB αΔ mutant) mice demonstrate an antidepressant phenotype in the tail suspension test (TST) and forced-swim test. Here, we show that, at baseline, CREB αΔ mutant mice exhibited increased hippocampal cell proliferation and neurogenesis compared with wild-type (WT) controls, effects similar to those observed in WT mice after chronic desipramine (DMI) administration. Neurogenesis was not further augmented by chronic DMI treatment in CREB αΔ mutant mice. Serotonin depletion decreased neurogenesis in CREB αΔ mutant mice to WT levels, which correlated with a reversal of the antidepressant phenotype in the TST. This effect was specific for the reversal of the antidepressant phenotype in these mice, because serotonin depletion did not alter a baseline anxiety-like behavior in CREB αΔ mutant mice. The response to chronic AD treatment in the novelty-induced hypophagia (NIH) test may rely on neurogenesis. Therefore, we used this paradigm to evaluate chronic AD treatment in CREB αΔ mutant mice to determine whether the increased neurogenesis in these mice alters their response in the NIH paradigm. Whereas both WT and CREB αΔ mutant mice responded to chronic AD treatment in the NIH paradigm, only CREB αΔ mutant mice responded to acute AD treatment. However, in the elevated zero maze, DMI did not reverse anxiety behavior in mutant mice. Together, these data show that increased hippocampal neurogenesis allows for an antidepressant phenotype as well as a rapid onset of behavioral responses to AD treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · cited 1×
“The notion that reduced hippocampal neurogenesis is involved in the pathophysiology of depression has gained traction in recent years (Dranovsky and Hen, 2006; Duman and Monteggia, 2006).”
BackgroundNestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111
Self-citationLearning enhances adult neurogenesis in the hippocampal formation
Gould, E., Beylin, A., Tanapat, P., Reeves, A., & Shors, T. J. (1999) · Nature Neuroscience · doi:10.1038/6365 · Cited by 2,157 · cited 1×
“Similar to previous reports, the total number of BrdU-positive cells after 6 weeks was lower compared with that at 24 h (Gould et al., 1999; Malberg et al., 2000; Nakagawa et al., 2002a).”
ResultSTRESS AND HIPPOCAMPAL PLASTICITY
McEwen, B. S. (1999) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.22.1.105 · Cited by 2,087 · cited 1×
“Hippocampal atrophy is hypothesized to be one contributing factor to the affective and cognitive impairments observed in depression (Watanabe et al., 1992; Stein-Behrens et al., 1994; Magarinos et al., 1996; Sheline, 1996; McEwen, 1999; Sheline et al., 2003).”
BackgroundCryan, J. F., Mombereau, C., & Vassout, A. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.009 · Cited by 1,674
Adult neurogenesis produces a large pool of new granule cells in the dentate gyrus
Cameron, H. A., & Mckay, R. D. G. (2001) · Journal of Comparative Neurology · doi:10.1002/cne.1040 · Cited by 1,585 · cited 1×
“This 2 h time point was chosen because it represents one cell cycle of labeling (Cameron and McKay, 2001) and is thought to be an accurate measure of cell proliferation (Malberg et al.”
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551 · cited 1×
“The FST and the TST are commonly used to assess antidepressant effects of drugs and, more recently, depressive phenotypes in mice (Cryan et al., 2002).”
BackgroundSelf-citationThe developmental role of serotonin: news from mouse molecular genetics
Gaspar, P., Cases, O., & Maroteaux, L. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1256 · Cited by 1,297
Stress induces atrophy of apical dendrites of hippocampal CA3 pyramidal neurons
Watanabe, Y., Gould, E., & McEwen, B. S. (1992) · Brain Research · doi:10.1016/0006-8993(92)91597-8 · Cited by 1,212 · cited 1×
“Hippocampal atrophy is hypothesized to be one contributing factor to the affective and cognitive impairments observed in depression (Watanabe et al., 1992; Stein-Behrens et al., 1994; Magarinos et al., 1996; Sheline, 1996; McEwen, 1999; Sheline et al., 2003).”
BackgroundNibuya, M., Nestler, E., & Duman, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-07-02365.1996 · Cited by 1,206
Untreated Depression and Hippocampal Volume Loss
Sheline, Y. I., Gado, M. H., & Kraemer, H. C. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.8.1516 · Cited by 1,180 · cited 1×
“Hippocampal atrophy is hypothesized to be one contributing factor to the affective and cognitive impairments observed in depression (Watanabe et al., 1992; Stein-Behrens et al., 1994; Magarinos et al., 1996; Sheline, 1996; McEwen, 1999; Sheline et al., 2003).”
BackgroundMagariños, A. M., McEwen, B. S., Flügge, G., & Fuchs, E. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-10-03534.1996 · Cited by 864
Sairanen, M., Lucas, G., Ernfors, P., Castrén, M., & Castrén, E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3741-04.2005 · Cited by 763 · cited 1×
“AD drugs that increase neurogenesis in the dentate gyrus of the adult hippocampus plausibly counteract this pathology of depression (Malberg et al., 2000; Czeh et al., 2001; Manev et al., 2001; Santarelli et al., 2003; Kodama et al., 2004; Sairanen et al., 2005).”
BackgroundHippocampal Neurogenesis: Regulation by Stress and Antidepressants
Dranovsky, A., & Hen, R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.082 · Cited by 663
Research and treatment approaches to depression
Wong, M.-L., & Licinio, J. (2001) · Nature Reviews Neuroscience · doi:10.1038/35072566 · Cited by 656 · cited 1×
“Antidepressant (AD) treatment involves amelioration of symptoms over the course of weeks or months (Wong and Licinio, 2001).”
BackgroundPliakas, A. M., Carlson, R. R., Neve, R. L., Konradi, C., Nestler, E. J., & Carlezon, W. A. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07397.2001 · Cited by 509
VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants
Warner-Schmidt, J. L., & Duman, R. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0610282104 · Cited by 438 · cited 1×
“In previous rat studies, treatment with fluoxetine increased the number of BrdU-labeled cells by 20 – 40%, whereas electroconvulsive seizure caused a 50% increase (Malberg et al., 2000; Warner-Schmidt and Duman, 2007).”
BackgroundKodama, M., Fujioka, T., & Duman, R. S. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.07.008 · Cited by 387 · cited 1×
“AD drugs that increase neurogenesis in the dentate gyrus of the adult hippocampus plausibly counteract this pathology of depression (Malberg et al., 2000; Czeh et al., 2001; Manev et al., 2001; Santarelli et al., 2003; Kodama et al., 2004; Sairanen et al., 2005).”
BackgroundThe Role of CREB in Depression and Antidepressant Treatment
Blendy, J. A. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.11.003 · Cited by 365 · cited 2×
“However by binding to CRE sequences in DNA, mCREB may target genes that are not normally regulated by CREB (Blendy, 2006), thereby altering neurogenesis through other mechanisms.”
BackgroundSelf-citationDo animal models of anxiety predict anxiolytic-like effects of antidepressants?
Borsini, F., Podhorna, J., & Marazziti, D. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1155-6 · Cited by 347 · cited 1×
“Depending on the test used and the AD administered, many studies have reported no effect or an anxiogenic effect (Borsini et al., 2002).”
Stress exacerbates neuron loss and cytoskeletal pathology in the hippocampus
Stein-Behrens, B., Mattson, M., Chang, I., Yeh, M., & Sapolsky, R. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-09-05373.1994 · Cited by 327 · cited 1×
“Hippocampal atrophy is hypothesized to be one contributing factor to the affective and cognitive impairments observed in depression (Watanabe et al., 1992; Stein-Behrens et al., 1994; Magarinos et al., 1996; Sheline, 1996; McEwen, 1999; Sheline et al., 2003).”
BackgroundNewton, S. S., Thome, J., Wallace, T. L., Shirayama, Y., Schlesinger, L., Sakai, N., Chen, J., Neve, R., Nestler, E. J., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-24-10883.2002 · Cited by 313
Delayed pharmacological effects of antidepressants
Frazer, A., & Benmansour, S. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001015 · Cited by 160
Validation of a simple, ethologically relevant paradigm for assessing anxiety in mice
Merali, Z., Levac, C., & Anisman, H. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01827-9 · Cited by 157 · cited 3×
“In these paradigms, latency to consume food in a novel environment is measured and chronic but not acute AD treatment, as well as acute benzodiazepine treatment, reduces the latency to feed in a novel environment (Merali et al., 2003; Dulawa and Hen, 2005).”
BackgroundAnxiolytic effect of serotonin depletion in the novelty-induced hypophagia test
Bechtholt, A. J., Hill, T. E., & Lucki, I. (2007) · Psychopharmacology · doi:10.1007/s00213-006-0615-9 · Cited by 48
Self-citation
Cited by
Mechanisms and Functional Implications of Adult Neurogenesis
Zhao, C., Deng, W., & Gage, F. H. (2008) · Cell · doi:10.1016/j.cell.2008.01.033 · Cited by 3,007
The GABAergic deficit hypothesis of major depressive disorder
Luscher, B., Shen, Q., & Sahir, N. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.120 · Cited by 934
Wang, H., Xu, J., Lazarovici, P., Quirion, R., & Zheng, W. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00255 · Cited by 436
Balu, D. T., & Lucki, I. (2009) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2008.08.007 · Cited by 383
Self-citationmicroRNA-132 regulates dendritic growth and arborization of newborn neurons in the adult hippocampus
Magill, S. T., Cambronne, X. A., Luikart, B. W., Lioy, D. T., Leighton, B. H., Westbrook, G. L., Mandel, G., & Goodman, R. H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015691107 · Cited by 363
Metadata
- Authors
- Gur, T. L., Conti, A. C., Holden, J., Bechtholt, A. J., Hill, T. E., Lucki, I., Malberg, J. E., & Blendy, J. A.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2007-07-18
- Volume
- 27
- Issue
- 29
- Pages
- 7860-7868
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2148186685
- Cited by
- 101
- References
- 26
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.